This is a demo store. No orders will be fulfilled.

Vital Signs - The Analyst's Perspective - May 2015 Issue

Vital Signs - The Analyst's Perspective - May 2015 Issue

RELEASE DATE
30-Jun-2015
REGION
Asia Pacific
Research Code: 9A35-00-37-00-00
SKU: HC02614-AP-MR_16736
$450.00
In stock
SKU
HC02614-AP-MR_16736
$450.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This issue of Vital Signs, released on June 8, 2015, discusses cholesterol lowering drugs from Amgen and Sanofi/Regeneron, LabCorp's new offering of direct-to-consumer testing, Apple's foray into collecting genetic information from users, and Danaher's acquisition of Pall.

Table of Contents

This market insight presents an overview and analysis of the Singaporean CRO market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The research study discusses the major issues and challenges, unmet needs, and emerging trends in the market. The study covers the complete life cycle of the CRO industry, from preclinical trials to post-marketing surveillance. It provides detailed information on support services, such as central laboratory services, bio-analytics, and data management. The market insight also analyses Market Engineering measurements, and R&D trends.
More Information
No Index No
Podcast No
Author Christi Bird
Industries Healthcare
WIP Number 9A35-00-37-00-00
Is Prebook No